Sign in
4

Changes in Ownership

Elicio Therapeutics, Inc. Filed Acc 0001628280-22-015238

Director bought 9,383 shares at an average $1.16 ($10,925)

From the SEC's structured data for this filing

Trades in this filing

Nissenson Allen · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-19 Purchase : show line 1 in the form +7,346 $1.16 $8,521 7,346 D
2022-05-20 Purchase : show line 2 in the form +2,037 $1.18 $2,404 9,383 D
Open-market purchases · 9,383 sh · avg $1.16 · $10,925
Loading xslF345X03/wf-form4_165334970201347.xml…